While Shareholders of Inspire Medical Systems (NYSE:INSP) Are in the Black Over 5 Years, Those Who Bought a Week Ago Aren't so Fortunate
While Shareholders of Inspire Medical Systems (NYSE:INSP) Are in the Black Over 5 Years, Those Who Bought a Week Ago Aren't so Fortunate
Inspire Medical Systems, Inc. (NYSE:INSP) shareholders might understandably be very concerned that the share price has dropped 47% in the last quarter. But that doesn't change the fact that shareholders have received really good returns over the last five years. We think most investors would be happy with the 244% return, over that period. Generally speaking the long term returns will give you a better idea of business quality than short periods can. Only time will tell if there is still too much optimism currently reflected in the share price.
Inspire醫療系統公司(紐約證券交易所股票代碼:INSP)的股東可能會非常擔心上個季度股價下跌了47%,這是可以理解的。但這並沒有改變這樣一個事實,即股東在過去五年裡獲得了非常好的回報。我們認為,大多數投資者會對這段時間244%的回報率感到滿意。一般來說,長期回報會讓你比短期回報更好地瞭解業務質量。目前反映在股價中的樂觀情緒是否仍然過多,只有時間才能證明。
While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.
雖然過去一週該公司的五年回報率有所下降,但讓我們來看看基本業務的近期趨勢,看看收益是否一致。
View our latest analysis for Inspire Medical Systems
查看我們對Inspire醫療系統的最新分析
Inspire Medical Systems isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.
Inspire Medical Systems目前沒有盈利,因此大多數分析師都會關注收入增長,以瞭解基礎業務的增長速度。當一家公司沒有盈利時,我們通常預計會看到良好的收入增長。這是因為快速的收入增長可以很容易地推斷出預期利潤,通常是相當大的規模。
In the last 5 years Inspire Medical Systems saw its revenue grow at 49% per year. That's well above most pre-profit companies. So it's not entirely surprising that the share price reflected this performance by increasing at a rate of 28% per year, in that time. This suggests the market has well and truly recognized the progress the business has made. Inspire Medical Systems seems like a high growth stock - so growth investors might want to add it to their watchlist.
在過去的5年裡,Inspire醫療系統公司的收入以每年49%的速度增長。這遠遠高於大多數盈利前的公司。因此,在此期間,股價以每年28%的速度增長來反映這種表現也就不足為奇了。這表明市場已經很好地、真正地認識到了業務取得的進展。Inspire Medical Systems似乎是一隻高增長的股票--因此成長型投資者可能希望將其添加到他們的觀察名單中。
The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).
下圖顯示了收益和收入隨時間的變化情況(如果您點擊該圖,您可以看到更多詳細資訊)。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231026/0-364871267b7187fd484e0d6b5fd16c47-0-d2f2352556849b7200bc601a8945cb6b.png/big)
Inspire Medical Systems is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.
Inspire Medical Systems是一隻著名的股票,有大量的分析師報道,這表明未來的增長具有一定的可見性。鑑於我們有相當多的分析師預測,可能很值得查看以下內容免費描繪共識估計的圖表。
A Different Perspective
不同的視角
Investors in Inspire Medical Systems had a tough year, with a total loss of 17%, against a market gain of about 9.9%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 28% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. You might want to assess this data-rich visualization of its earnings, revenue and cash flow.
Inspire Medical Systems的投資者經歷了艱難的一年,總虧損17%,而市場收益約為9.9%。即使是好股票的股價有時也會下跌,但我們希望在對企業產生太大興趣之前,看到企業的基本指標有所改善。從好的方面來看,長期股東已經賺到了錢,過去五年的年回報率為28%。如果基本面數據繼續顯示長期可持續增長,當前的拋售可能是一個值得考慮的機會。你可能想要評估一下它的收益、收入和現金流的這種數據豐富的可視化。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費我們預計收益將會增長的公司名單。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.